QED Therapeutics
Get verified emails for QED Therapeutics employees
About QED Therapeutics
|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
421 Kipling St., Palo Alto, CA 94301, US
|
|
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
|
QED Therapeutics Email Format
The widely used QED Therapeutics email format is {f}{last}@qedtx.com (e.g. [email protected]), which is used 75.00% of the time.
| QED Therapeutics Email Formats | Example Email Formats | Percentage |
|---|---|---|
| {f}{last} | [email protected] |
75.00%
|
QED Therapeutics Alternatives
Frequently Asked Questions about QED Therapeutics
What is QED Therapeutics email format?
The widely used QED Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
What is QED Therapeutics customer service number?
To contact QED Therapeutics customer service number in your country click here to find.
QED Therapeutics Staff Directory
Search QED Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
